Swiss National Bank’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $379K | Sell |
50,300
-12,400
| -20% | -$93.4K | ﹤0.01% | 2324 |
|
|
2025
Q1 | $475K | Hold |
62,700
| – | – | ﹤0.01% | 2344 |
|
|
2024
Q4 | $764K | Sell |
62,700
-10,900
| -15% | -$133K | ﹤0.01% | 2312 |
|
|
2024
Q3 | $1.23M | Hold |
73,600
| – | – | ﹤0.01% | 2119 |
|
|
2024
Q2 | $1.28M | Buy |
73,600
+27,300
| +59% | +$476K | ﹤0.01% | 2047 |
|
|
2024
Q1 | $789K | Hold |
46,300
| – | – | ﹤0.01% | 2329 |
|
|
2023
Q4 | $472K | Buy |
46,300
+7,700
| +20% | +$78.5K | ﹤0.01% | 2485 |
|
|
2023
Q3 | $349K | Hold |
38,600
| – | – | ﹤0.01% | 2569 |
|
|
2023
Q2 | $415K | Buy |
38,600
+9,000
| +30% | +$96.8K | ﹤0.01% | 2566 |
|
|
2023
Q1 | $303K | Sell |
29,600
-3,400
| -10% | -$34.8K | ﹤0.01% | 2605 |
|
|
2022
Q4 | $348K | Buy |
33,000
+2,100
| +7% | +$22.2K | ﹤0.01% | 2635 |
|
|
2022
Q3 | $396K | Hold |
30,900
| – | – | ﹤0.01% | 2629 |
|
|
2022
Q2 | $396K | Sell |
30,900
-5,300
| -15% | -$67.9K | ﹤0.01% | 2665 |
|
|
2022
Q1 | $379K | Buy |
36,200
+2,700
| +8% | +$28.3K | ﹤0.01% | 2635 |
|
|
2021
Q4 | $517K | Buy |
33,500
+4,900
| +17% | +$75.6K | ﹤0.01% | 2658 |
|
|
2021
Q3 | $646K | Hold |
28,600
| – | – | ﹤0.01% | 2540 |
|
|
2021
Q2 | $736K | Buy |
+28,600
| New | +$736K | ﹤0.01% | 2565 |
|